Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Orexo

23.30 SEK

-1.89 %

Less than 1K followers

ORX

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orexo

2019202020212022202320242025
Revenue844.8663.6565.0624.3638.8590.026.0
growth-%-21.4 %-14.9 %10.5 %2.3 %-7.6 %-95.6 %
EBITDA272.219.0-161.1-180.4-9.723.4772.3
EBIT231.2-19.9-214.1-183.9-109.5-140.3-352.7
Profit before taxes227.9-38.3-222.5-170.4-140.3-190.6-403.0
Net income219.1-84.4-223.5-177.6-128.3-203.0639.3
EPS6.33-2.44-6.51-5.17-3.73-5.8918.46
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%32.2 %2.9 %-28.5 %-28.9 %-1.5 %4.0 %2,970.4 %
EBIT-%27.4 %-3.0 %-37.9 %-29.5 %-17.1 %-23.8 %-1,356.5 %
ROE31.0 %-15.1 %-63.9 %-91.6 %-217.8 %160.7 %130.3 %
ROI14.6 %-6.8 %-17.5 %-16.0 %-16.3 %-34.1 %49.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.